Amiodarone Hydrochloride Tablet
NDC Package 65841-841-06
Package Information
Amiodarone Hydrochloride tablets is classified as a
- antiarrhythmic - [epc] (established pharmacologic class)
- cytochrome p450 1a2 inhibitors - [moa] (mechanism of action)
- cytochrome p450 2c9 inhibitors - [moa] (mechanism of action)
- cytochrome p450 2d6 inhibitors - [moa] (mechanism of action)
- cytochrome p450 3a inhibitors - [moa] (mechanism of action)
- p-glycoprotein inhibitors - [moa] (mechanism of action)
Identification & Billing
- RxCUI: 833528 - amiodarone HCl 200 MG Oral Tablet
- RxCUI: 833528 - amiodarone hydrochloride 200 MG Oral Tablet
- RxCUI: 834348 - amiodarone HCl 400 MG Oral Tablet
- RxCUI: 834348 - amiodarone hydrochloride 400 MG Oral Tablet
- RxCUI: 835956 - amiodarone HCl 100 MG Oral Tablet
Clinical Specifications
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Cytochrome P450 1A2 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2C9 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 2D6 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- P-Glycoprotein Inhibitors - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 65841 - Zydus Lifesciences Limited
- 65841-841 - Amiodarone Hydrochloride
- 65841-841-06 - 30 TABLET in 1 BOTTLE
- 65841-841 - Amiodarone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65841-841-06 identifies a specific commercial package of 30 tablet in 1 bottle of Amiodarone Hydrochloride, a human prescription drug labeled by Zydus Lifesciences Limited. This tablet is formulated for oral use and contains amiodarone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Lifesciences Limited on February 09, 2023. The current certification is valid through December 31, 2027.
How is this Zydus Lifesciences Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65841084106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.